|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-2-11
|
|
pubmed:abstractText |
To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
353-63
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14872476-Adult,
pubmed-meshheading:14872476-Aged,
pubmed-meshheading:14872476-Aged, 80 and over,
pubmed-meshheading:14872476-Antirheumatic Agents,
pubmed-meshheading:14872476-Arthritis, Rheumatoid,
pubmed-meshheading:14872476-C-Reactive Protein,
pubmed-meshheading:14872476-Double-Blind Method,
pubmed-meshheading:14872476-Drug Administration Schedule,
pubmed-meshheading:14872476-Female,
pubmed-meshheading:14872476-Health Status,
pubmed-meshheading:14872476-Humans,
pubmed-meshheading:14872476-Immunoglobulin G,
pubmed-meshheading:14872476-Injections, Subcutaneous,
pubmed-meshheading:14872476-Joints,
pubmed-meshheading:14872476-Male,
pubmed-meshheading:14872476-Middle Aged,
pubmed-meshheading:14872476-Pain Measurement,
pubmed-meshheading:14872476-Placebos,
pubmed-meshheading:14872476-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:14872476-Severity of Illness Index,
pubmed-meshheading:14872476-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
Mt. Sinai Hospital, Toronto, Ontario, Canada. edkeystone@mtsinai.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
